BABA vs MMYT

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

MMYT exhibits a strong deterministic health profile with a Piotroski F-Score of 7/9, indicating robust operational efficiency and financial stability. However, there is a severe valuation disconnect, as the current price of $44.62 trades at a massive premium to the growth-based intrinsic value of $3.64 and shows a negative Price/Book ratio. While the Forward P/E of 20.95 suggests a significant earnings recovery is expected, the technical trend remains bearish following a 54.5% one-year decline. The stock is currently a battle between strong fundamental health/analyst optimism and poor valuation/price momentum.